Abstract

The process wherein dividing cells exhaust proliferative capacity and enter into replicative senescence has become a prominent model for cellular aging in vitro. Despite decades of study, this cellular state is not fully understood in culture and even much less so during aging. Here, we revisit Leonard Hayflick’s original observation of replicative senescence in WI-38 human lung fibroblasts equipped with a battery of modern techniques including RNA-seq, single cell RNA-seq, proteomics, metabolomics, and ATAC-seq. We find evidence that the transition to a senescent state manifests early, increases gradually, and corresponds to a concomitant global increase in DNA accessibility in nucleolar and lamin associated domains. Furthermore, we demonstrate that senescent WI-38 cells acquire a striking resemblance to myofibroblasts in a process similar to the epithelial to mesenchymal transition (EMT) that is regulated by the transcription factors YAP1/TEAD1 and TGF-𝛽2. Lastly, we show that verteporfin inhibition of YAP1/TEAD1 activity in aged WI-38 cells robustly attenuates this gene expression program.

Data availability

Sequencing data have been deposited in GEO under accession code GSE175533.Proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository under accession code EBI PRIDECode for processing and analyzing data modalities have been deposited at https://github.com/dghendrickson/hayflickSource data for figures and analysis have been deposited at https://github.com/dghendrickson/hayflick and/or uploaded as source data files.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Michelle Chan

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Michelle Chan, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare..
  2. Han Yuan

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Han Yuan, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare..
  3. Ilya Soifer

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Ilya Soifer, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare..
  4. Tobias M Maile

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Tobias M Maile, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare..
  5. Rebecca Y Wang

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Rebecca Y Wang, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare..
  6. Andrea Ireland

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Andrea Ireland, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare..
  7. Jonathon J O'Brien

    Calico Life Sciences LLC, South San Francisco, United States
    Competing interests
    Jonathon J O'Brien, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9660-4797
  8. Jérôme Goudeau

    Calico Life Sciences LLC, South San Francisco, United States
    Competing interests
    Jérôme Goudeau, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2483-1955
  9. Leanne JG Chan

    Calico Life Sciences LLC, South San Francisco, United States
    Competing interests
    Leanne JG Chan, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
  10. Twaritha Vijay

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Twaritha Vijay, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
  11. Adam Freund

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Adam Freund, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7956-5332
  12. Cynthia Kenyon

    Calico Life Sciences LLC, South San Francisco, United States
    Competing interests
    Cynthia Kenyon, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3446-2636
  13. Bryson D Bennett

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Bryson D Bennett, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
  14. Fiona E McAllister

    Calico Life Sciences LLC, South San Francisco, United States
    Competing interests
    Fiona E McAllister, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
  15. David R Kelley

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    David R Kelley, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
  16. Margaret Roy

    Calico Life Sciences LLC, South San Francisco, United States
    Competing interests
    Margaret Roy, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
  17. Robert L Cohen

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Robert L Cohen, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
  18. Arthur D Levinson

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Arthur D Levinson, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
  19. David Botstein

    Calico Life Sciences, LLC, South San Francisco, United States
    For correspondence
    botstein@calicolabs.com
    Competing interests
    David Botstein, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
  20. David G Hendrickson

    Calico Life Sciences, LLC, South San Francisco, United States
    For correspondence
    dgh@calicolabs.com
    Competing interests
    David G Hendrickson, is affiliated with Calico Life Sciences, LLC. The author has no other competing interests to declare.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1884-5234

Funding

The authors are employed by Calico Sciences, and no external funding was received.

Copyright

© 2022, Chan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 9,405
    views
  • 1,356
    downloads
  • 52
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michelle Chan
  2. Han Yuan
  3. Ilya Soifer
  4. Tobias M Maile
  5. Rebecca Y Wang
  6. Andrea Ireland
  7. Jonathon J O'Brien
  8. Jérôme Goudeau
  9. Leanne JG Chan
  10. Twaritha Vijay
  11. Adam Freund
  12. Cynthia Kenyon
  13. Bryson D Bennett
  14. Fiona E McAllister
  15. David R Kelley
  16. Margaret Roy
  17. Robert L Cohen
  18. Arthur D Levinson
  19. David Botstein
  20. David G Hendrickson
(2022)
Novel insights from a multiomics dissection of the Hayflick limit
eLife 11:e70283.
https://doi.org/10.7554/eLife.70283

Share this article

https://doi.org/10.7554/eLife.70283

Further reading

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Bethany M Bartlett, Yatendra Kumar ... Wendy A Bickmore
    Research Article Updated

    During oncogene-induced senescence there are striking changes in the organisation of heterochromatin in the nucleus. This is accompanied by activation of a pro-inflammatory gene expression programme – the senescence-associated secretory phenotype (SASP) – driven by transcription factors such as NF-κB. The relationship between heterochromatin re-organisation and the SASP has been unclear. Here, we show that TPR, a protein of the nuclear pore complex basket required for heterochromatin re-organisation during senescence, is also required for the very early activation of NF-κB signalling during the stress-response phase of oncogene-induced senescence. This is prior to activation of the SASP and occurs without affecting NF-κB nuclear import. We show that TPR is required for the activation of innate immune signalling at these early stages of senescence and we link this to the formation of heterochromatin-enriched cytoplasmic chromatin fragments thought to bleb off from the nuclear periphery. We show that HMGA1 is also required for cytoplasmic chromatin fragment formation. Together these data suggest that re-organisation of heterochromatin is involved in altered structural integrity of the nuclear periphery during senescence, and that this can lead to activation of cytoplasmic nucleic acid sensing, NF-κB signalling, and activation of the SASP.

    1. Chromosomes and Gene Expression
    2. Evolutionary Biology
    Timothy Fuqua, Yiqiao Sun, Andreas Wagner
    Research Article

    Gene regulation is essential for life and controlled by regulatory DNA. Mutations can modify the activity of regulatory DNA, and also create new regulatory DNA, a process called regulatory emergence. Non-regulatory and regulatory DNA contain motifs to which transcription factors may bind. In prokaryotes, gene expression requires a stretch of DNA called a promoter, which contains two motifs called –10 and –35 boxes. However, these motifs may occur in both promoters and non-promoter DNA in multiple copies. They have been implicated in some studies to improve promoter activity, and in others to repress it. Here, we ask whether the presence of such motifs in different genetic sequences influences promoter evolution and emergence. To understand whether and how promoter motifs influence promoter emergence and evolution, we start from 50 ‘promoter islands’, DNA sequences enriched with –10 and –35 boxes. We mutagenize these starting ‘parent’ sequences, and measure gene expression driven by 240,000 of the resulting mutants. We find that the probability that mutations create an active promoter varies more than 200-fold, and is not correlated with the number of promoter motifs. For parent sequences without promoter activity, mutations created over 1500 new –10 and –35 boxes at unique positions in the library, but only ~0.3% of these resulted in de-novo promoter activity. Only ~13% of all –10 and –35 boxes contribute to de-novo promoter activity. For parent sequences with promoter activity, mutations created new –10 and –35 boxes in 11 specific positions that partially overlap with preexisting ones to modulate expression. We also find that –10 and –35 boxes do not repress promoter activity. Overall, our work demonstrates how promoter motifs influence promoter emergence and evolution. It has implications for predicting and understanding regulatory evolution, de novo genes, and phenotypic evolution.